Breaking News Instant updates and real-time market news.

GRFS

Grifols

$24.10

-0.605 (-2.45%)

, ARGX

Argenx

$98.39

-1.96 (-1.95%)

06:36
06/14/18
06/14
06:36
06/14/18
06:36

Grifols downgraded to Neutral ahead of competitor data at JPMorgan

JPMorgan analyst James Gordon last night downgraded Grifols to Neutral from Overweight and lowered his price target for the shares to $25.50 from $26.30. With 5% downside to consensus expectations in 2019 and 2020, the shares now look fully valued, Gordon tells investors in a research note. Further, the analyst sees competitor clinical data from Argenx (ARGX) and UCB in the second half of 2018 potentially raising questions as to the long-term sustainability of the auto-immune element of Grifols' immuno-globulin franchise.

GRFS

Grifols

$24.10

-0.605 (-2.45%)

ARGX

Argenx

$98.39

-1.96 (-1.95%)

  • 20

    Jun

GRFS Grifols
$24.10

-0.605 (-2.45%)

11/24/17
11/24/17
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. Deere (DE), upgraded to Buy from Hold at Deutsche Bank with analyst Nicole DeBlase saying positive earnings revisions should drive share outperformance from here. 2. Santander (SAN), upgraded to Buy from Neutral at Goldman Sachs. 3. Tim Participacoes (TSU), upgraded to Outperform from Market Perform at Itau BBA. 4. Grifols (GRFS), downgraded to Market Perform from Outperform at BBVA . 5. ZTO Express (ZTO), downgraded to Neutral from Buy at UBS with analyst Eric Lin citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/18
HSBC
03/14/18
UPGRADE
HSBC
Hold
Grifols upgraded to Hold from Reduce at HSBC
06/01/18
LEHM
06/01/18
INITIATION
LEHM
Overweight
Grifols initiated with an Overweight at Barclays
Barclays analyst Emily Field started Grifols with an Overweight rating and EUR 29 price target. The analyst views the company as the global leader in intravenous immunoglobulin therapy and thinks its investments "are about to pay off."
06/13/18
JPMS
06/13/18
DOWNGRADE
JPMS
Neutral
Grifols downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst James Gordon downgraded Grifols to Neutral with an unchanged price target of EUR 21.50. The analyst views the valuation as full at current share levels.
ARGX Argenx
$98.39

-1.96 (-1.95%)

11/16/17
WEDB
11/16/17
NO CHANGE
Target $41
WEDB
Outperform
Argenx price target raised to $41 from $26 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Argenx to $41 from $26 as he incorporates the pemphigus vulgaris market opportunity into his valuation. The analyst reiterates an Outperform rating on the shares.
12/19/17
PIPR
12/19/17
NO CHANGE
Target $100
PIPR
Overweight
Argenx price target raised to $100 from $32 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Argenx to $100 citing last week's positive Phase II efgartigimod data in myasthenia gravis. The analyst believes these data validate efgartigimod's mechanism of targeting FcRn to lower auto-antibodies to treat a broad range of autoimmune diseases. He reiterates an Overweight rating on Argenx shares.
04/09/18
RHCO
04/09/18
INITIATION
Target $125
RHCO
Buy
Argenx initiated with a Buy at SunTrust
SunTrust analyst Yatin Suneja initiated Argenx with a Buy rating and a price target of $125, saying the company is leveraging a proprietary antibody generation platform as its lead candidate ARGX-113 holds blockbuster potential in multiple autoimmune conditions. With the "solid proof-of-concept" already established in rare neuromuscular disease, the analyst contends that ARGX-113 could also have positive readouts in other indications. Suneja adds that Argenx's second asset - ARGX-110 - also has an "encouraging" potential in the early clinical data in leukemia.
06/07/18
PIPR
06/07/18
NO CHANGE
Target $130
PIPR
Overweight
Argenx price target raised to $130 from $100 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Argenx to $130 after the company reached an agreement with FDA to initiate a single Phase III trial of efgartigimod in generalized myasthenia gravis this year. Full Phase II data presented at the American Academy of Neurology conference showed "rapid and durable clinical benefit," Tenthoff tells investors in a research note. The analyst reiterates an Overweight rating on Argenx shares.

TODAY'S FREE FLY STORIES

CRM

Salesforce

$152.88

-3.12 (-2.00%)

, CPCAY

Cathay Pacific

$0.00

(0.00%)

21:04
09/19/18
09/19
21:04
09/19/18
21:04
Hot Stocks
Cathay Pacific to partner with Salesforce on digital transformation »

Salesforce (CRM)…

CRM

Salesforce

$152.88

-3.12 (-2.00%)

CPCAY

Cathay Pacific

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 03

    Mar

UCTT

Ultra Clean

$13.42

-0.13 (-0.96%)

21:02
09/19/18
09/19
21:02
09/19/18
21:02
Hot Stocks
Ultra Clean announces fire at a plant in Korea »

Ultra Clean Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$291.22

0.26 (0.09%)

, SPX

S&P 500

$0.00

(0.00%)

21:00
09/19/18
09/19
21:00
09/19/18
21:00
General news
President Trump to nominate Nellie Liang to Federal Reserve Board of Governors »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$291.22

0.26 (0.09%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EB

Eventbrite

$0.00

(0.00%)

20:53
09/19/18
09/19
20:53
09/19/18
20:53
Syndicate
Eventbrite 10M share IPO priced at $23.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

EFX

Equifax

$134.27

-3.78 (-2.74%)

20:40
09/19/18
09/19
20:40
09/19/18
20:40
Hot Stocks
Equifax UK arm fined GBP500K for security breach in 2017 »

The Information…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 06

    Nov

BSVN

Bank7

$0.00

(0.00%)

20:29
09/19/18
09/19
20:29
09/19/18
20:29
Syndicate
Bank7 3.4M share IPO priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

THO

Thor Industries

$105.72

2.44 (2.36%)

, DRI

Darden

$117.90

-1.03 (-0.87%)

20:25
09/19/18
09/19
20:25
09/19/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

THO

Thor Industries

$105.72

2.44 (2.36%)

DRI

Darden

$117.90

-1.03 (-0.87%)

SANW

S&W Seed

$3.15

0.1 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 11

    Oct

LGCY

Legacy Reserves

$4.78

-0.18 (-3.63%)

19:34
09/19/18
09/19
19:34
09/19/18
19:34
Initiation
Legacy Reserves initiated  »

Legacy Reserves initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMT

Core Molding

$7.75

-0.15 (-1.90%)

19:07
09/19/18
09/19
19:07
09/19/18
19:07
Hot Stocks
Core Molding names Eric Palomaki VP of Operations »

Core Molding Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMNI

Rimini Street

$6.92

0.33 (5.01%)

19:07
09/19/18
09/19
19:07
09/19/18
19:07
Hot Stocks
Rimini Street obtains Australian single touch payroll certification »

Rimini Street announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$37.30

0.2 (0.54%)

, LCI

Lannett

$4.85

0.15 (3.19%)

18:56
09/19/18
09/19
18:56
09/19/18
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Herman…

MLHR

Herman Miller

$37.30

0.2 (0.54%)

LCI

Lannett

$4.85

0.15 (3.19%)

AVP

Avon Products

$2.32

0.03 (1.31%)

NGD

New Gold

$1.10

0.03 (2.80%)

AMD

AMD

$31.20

-0.73 (-2.29%)

RHT

Red Hat

$143.38

0.59 (0.41%)

MTEM

Molecular Templates

$6.25

2.15 (52.44%)

CRSP

Crispr Therapeutics

$51.90

-1.27 (-2.39%)

KOS

Kosmos

$9.35

0.04 (0.43%)

VKTX

Viking Therapeutics

$19.64

0.17 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 23

    Sep

  • 27

    Sep

  • 01

    Oct

  • 20

    Sep

  • 21

    Sep

  • 21

    Sep

  • 21

    Sep

LCI

Lannett

$4.85

0.15 (3.19%)

18:49
09/19/18
09/19
18:49
09/19/18
18:49
Hot Stocks
Breaking Hot Stocks news story on Lannett »

MintBroke International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.43

-0.86 (-1.01%)

18:43
09/19/18
09/19
18:43
09/19/18
18:43
Periodicals
Nike has sold out 61% more merchandise after Kaepernick ad, Reuters says »

Nike has sold out 61%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 25

    Sep

ADVM

Adverum Biotechnologies

$5.85

0.05 (0.86%)

18:38
09/19/18
09/19
18:38
09/19/18
18:38
Hot Stocks
Adverum Biotechnologies receives fast track designation for ADVM022 gene therapy »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

BTI

British American Tobacco

$46.87

-0.475 (-1.00%)

18:11
09/19/18
09/19
18:11
09/19/18
18:11
Hot Stocks
British American Tobacco CEO Durante to retire April 1, 2019 »

British American Tobacco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$13.75

0.25 (1.85%)

18:02
09/19/18
09/19
18:02
09/19/18
18:02
Hot Stocks
Kearny Financial declares special cash dividend of 16c per share »

Kearny Financial has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVA

Avista

$51.50

0.01 (0.02%)

18:00
09/19/18
09/19
18:00
09/19/18
18:00
Hot Stocks
Avista, Hydro One extend merger end date »

Hydro One Limited and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,926.27

-14.93 (-0.77%)

17:57
09/19/18
09/19
17:57
09/19/18
17:57
Periodicals
Amazon leaks new Alexa smart plug and a subwoofer, Verge says »

According to the Verge,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$163.06

2.75 (1.72%)

17:45
09/19/18
09/19
17:45
09/19/18
17:45
Periodicals
Facebook sets up 'War Room' for safeguarding elections, NY Times says »

After Facebook gained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

RRTS

Roadrunner

$1.16

-0.065 (-5.33%)

17:45
09/19/18
09/19
17:45
09/19/18
17:45
Syndicate
Roadrunner files S-1 for rights offering to existing holders »

Roadrunner announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$26.45

0.3 (1.15%)

17:35
09/19/18
09/19
17:35
09/19/18
17:35
Hot Stocks
Associated Banc-Corp announces $200M share repurchase program »

Associated's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLIN

Bridgeline Digital

$1.02

-0.01 (-0.98%)

17:32
09/19/18
09/19
17:32
09/19/18
17:32
Syndicate
Breaking Syndicate news story on Bridgeline Digital »

Bridgeline Digital files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$1.10

0.03 (2.80%)

17:29
09/19/18
09/19
17:29
09/19/18
17:29
Hot Stocks
New Gold sells Mesquite Mine to Eqiunox Gold for $158M »

New Gold has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.22

0.26 (0.09%)

17:23
09/19/18
09/19
17:23
09/19/18
17:23
Periodicals
Trudeau wants to see more U.S. flexibility around NAFTA, Reuters says »

Canadian prime minister…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.22

0.26 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$339.26

-3.94 (-1.15%)

17:18
09/19/18
09/19
17:18
09/19/18
17:18
Hot Stocks
Lockheed Martin awarded $132.3M U.S. Navy contract modification »

Lockheed Martin Rotary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.